Hermansen JU, Kong W, Brodersen AM, Yin Y, Urban A, Rein ID, He L, Agius R, Teglgaard RS, Rousu J, Brieghel C, Kersting S, Levin MD, Tran HTT, Mattsson M, Ranti J, Veldhuis GJ, da Cunha-Bang C, Mous R, Dubois J, Kater AP, Enserink JM, Niemann CU, Aittokallio T, Skånland SS(2026) A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax Hemasphere, 10(9), e70467 DOI 10.1002/hem3.70467, PubMed 42757031
Ullern H, Johannessen JA, Kasikci F, Formica M, Karimi Melve N, Andresen S, Brech A, Axcrona K, Jørgensen K, Farkas L, Enserink JM, Knævelsrud H(2026) FLCN loss is characterized by SQSTM1/p62 accumulation despite functional autophagy flux in Birt-Hogg-Dubé syndrome-associated kidney cancer Autophagy Rep, 5(1), 2705631 DOI 10.1080/27694127.2026.2705631, PubMed 42569319
Willoch-Allen K, Zhao Z, Ayuda-Durán P, Mikaeloff F, Struyf N, Österroos A, Lehmann S, Kallioniemi O, Saarela J, Tyner JW, Erkers T, Enserink JM, Aittokallio T(2026) A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia NPJ Precis Oncol, 10(1) DOI 10.1038/s41698-026-01480-4, PubMed 42135420
Department of Molecular Cell Biology, Institute for Cancer Research The Norwegian Radium Hospital, Montebello, N-0379 Oslo, Norway Telephone +47 22 78 19 82 (Enserink), +47 22 78 12 59 (Dept. Secretary) Email: j.m.enserink@ibv.uio.no
